Yuan Li

8.1k total citations · 2 hit papers
217 papers, 5.8k citations indexed

About

Yuan Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuan Li has authored 217 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 60 papers in Oncology and 45 papers in Cancer Research. Recurrent topics in Yuan Li's work include Cancer-related molecular mechanisms research (22 papers), RNA modifications and cancer (17 papers) and Gastric Cancer Management and Outcomes (17 papers). Yuan Li is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), RNA modifications and cancer (17 papers) and Gastric Cancer Management and Outcomes (17 papers). Yuan Li collaborates with scholars based in China, United States and France. Yuan Li's co-authors include Anne Eichmann, Christiane Bréant, Luc Pardanaud, Delphine Moyon, Jiang‐Jiang Qin, Xiangdong Cheng, Kari Alitalo, Marika J. Karkkainen, Zhiyuan Xu and Ferdinand le Noble and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Yuan Li

203 papers receiving 5.7k citations

Hit Papers

Long non-coding RNAs towa... 2020 2026 2022 2024 2020 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Li China 38 3.5k 1.4k 1.3k 918 650 217 5.8k
Erxi Wu United States 46 3.1k 0.9× 1.8k 1.3× 1.3k 1.0× 562 0.6× 494 0.8× 164 6.7k
Lucia Morbidelli Italy 44 3.8k 1.1× 969 0.7× 1.2k 0.9× 495 0.5× 460 0.7× 146 7.8k
Young Kee Shin South Korea 49 4.3k 1.2× 1.6k 1.2× 1.4k 1.1× 516 0.6× 907 1.4× 200 8.0k
Ali Pedram United States 48 3.8k 1.1× 1.3k 1.0× 721 0.6× 663 0.7× 558 0.9× 78 9.2k
Claudio Arra Italy 47 3.5k 1.0× 1.6k 1.2× 1.1k 0.9× 360 0.4× 620 1.0× 162 6.5k
Anna Batistatou Greece 35 2.0k 0.6× 1.1k 0.8× 582 0.5× 531 0.6× 617 0.9× 201 4.5k
Xiao Zhang China 37 3.0k 0.9× 928 0.7× 1.6k 1.3× 336 0.4× 532 0.8× 176 5.3k
Rick F. Thorne Australia 42 3.5k 1.0× 727 0.5× 1.6k 1.2× 562 0.6× 331 0.5× 146 5.7k
Kyu‐Won Kim South Korea 58 5.8k 1.6× 1.3k 0.9× 2.5k 2.0× 578 0.6× 535 0.8× 207 10.5k

Countries citing papers authored by Yuan Li

Since Specialization
Citations

This map shows the geographic impact of Yuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Li more than expected).

Fields of papers citing papers by Yuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Li. The network helps show where Yuan Li may publish in the future.

Co-authorship network of co-authors of Yuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Li. A scholar is included among the top collaborators of Yuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Li. Yuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Kang, Zhengchen Jiang, Yuan Li, et al.. (2025). Multiomics insights into BMI-related intratumoral microbiota in gastric cancer. Frontiers in Cellular and Infection Microbiology. 15. 1511900–1511900. 2 indexed citations
2.
Zhao, Yuetao, Shuguang Wei, Zhao Chen, et al.. (2025). Lightweight Lung-nodule Detection Model Combined with Multidimensional Attention Convolution. Current Medical Imaging Formerly Current Medical Imaging Reviews. 21. e15734056310722–e15734056310722. 1 indexed citations
4.
Li, Yuan, et al.. (2024). Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro. International Immunopharmacology. 131. 111844–111844. 5 indexed citations
5.
Hu, Simeng, Can Hu, Jingli Xu, et al.. (2024). The estrogen response in fibroblasts promotes ovarian metastases of gastric cancer. Nature Communications. 15(1). 8447–8447. 9 indexed citations
6.
Chen, Jinxia, et al.. (2024). Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis. Cancer Medicine. 13(4). e7011–e7011. 4 indexed citations
7.
Chen, Jiahui, Yingying Sun, Mengge Lyu, et al.. (2024). In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study. Microbiome. 12(1). 6–6. 13 indexed citations
8.
Xiao, Jian, Jiawei Wang, Pengyu Li, et al.. (2024). Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer. Cancer Communications. 44(8). 855–878. 10 indexed citations
9.
Guan, Xiaoqing, Yichao Wang, Wen-Kai Yu, et al.. (2024). Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase. Advanced Science. 11(18). e2307899–e2307899. 39 indexed citations
10.
Kawasaki, Hiromi, et al.. (2023). Breast Cancer Screening and Perceptions of Harm among Young Adults in Japan: Results of a Cross-Sectional Online Survey. Current Oncology. 30(2). 2073–2087. 6 indexed citations
11.
Zhao, Jing, Yubo Ma, Li‐Bin Pan, et al.. (2023). Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway. Frontiers in Pharmacology. 14. 1143427–1143427. 6 indexed citations
12.
Li, Bin, Yichen Wang, Haiqing Chen, et al.. (2023). Pattern of tumor regression after neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma. Journal of Thoracic Disease. 15(10). 5517–5524. 3 indexed citations
13.
Wang, Yi, et al.. (2023). The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer. Langenbeck s Archives of Surgery. 408(1). 376–376. 1 indexed citations
14.
Li, Yuan, Shaowei Mo, Zhiyuan Xu, et al.. (2021). p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier. Pharmacological Research. 165. 105411–105411. 16 indexed citations
15.
Zeng, Qin, Yuan Li, Saber İmani, et al.. (2020). Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo. Journal of drug targeting. 28(9). 961–969. 12 indexed citations
16.
Yu, Dehua, Zhiyuan Xu, Shaowei Mo, et al.. (2020). Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges. Frontiers in Oncology. 10. 1389–1389. 34 indexed citations
17.
Li, Yuan, et al.. (2019). Canmei Formula Reduces Colitis-Associated Colorectal Carcinogenesis in Mice by Modulating the Composition of Gut Microbiota. Frontiers in Oncology. 9. 1149–1149. 29 indexed citations
18.
Liu, Xiaofeng, Yuan Li, Pengwei Ren, et al.. (2019). <p>miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression</p>. Cancer Management and Research. Volume 11. 5317–5332. 43 indexed citations
19.
Zhang, Kai, Leitao Sun, Yuan Li, et al.. (2018). Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition. Evidence-based Complementary and Alternative Medicine. 2018(1). 1495768–1495768. 9 indexed citations
20.
Eichmann, Anne, Luc Pardanaud, Yuan Li, & Delphine Moyon. (2002). Vasculogenesis and the Search for the Hemangioblast. Journal of Hematotherapy & Stem Cell Research. 11(2). 207–214. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026